MIIM
COLL icon

Mesirow Institutional Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Mesirow Institutional Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-436,189
Closed -$9.37M – 120
2023
Q2 		$9.37M Buy
436,189
+73,202
+20% +$1.66M 0.97% 62
2023
Q1 		$8.71M Buy
362,987
+72,453
+25% +$1.92M 0.95% 45
2022
Q4 		$6.74M Sell
290,534
-89,831
-24% -$1.81M 0.89% 70
2022
Q3 		$6.09M Buy
+380,365
New +$6.71M 0.88% 64

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Mesirow Institutional Investment Management's COLL Position: Q3 2023 in Review

Mesirow Institutional Investment Management sold out of Collegium Pharmaceutical (COLL) in Q3 2023, closing a stake of 436,189 shares — an estimated $9.37M sold.

Mesirow Institutional Investment Management first reported a position in COLL in Q3 2022 and held it in 4 quarters. The position peaked at $9.37M in Q2 2023. 174 funds tracked by Wall St. Rank hold COLL as of Q3 2023.

  • Mesirow Institutional Investment Management reported no remaining Collegium Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Mesirow Institutional Investment Management sold 436,189 Collegium Pharmaceutical shares in Q3 2023, an estimated $9.37M.
  • Mesirow Institutional Investment Management first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 4 quarters.
  • Mesirow Institutional Investment Management's Collegium Pharmaceutical position peaked at $9.37M in Q2 2023.
  • 174 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2023.

Based on Mesirow Institutional Investment Management's 13F filing for Q3 2023, filed 1 Nov 2023.